Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AB1 | P08238 | 19/20 | 0.59 |
| ▸ | HSP90AA1 | P07900 | 5/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | JAK2 | O60674 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3322211 | 0.93 | HSP90AB1 (0.57) | HSP90AB1HSP90AA1CYP2C19JAK2 | |
| SCHEMBL31170815 | 0.88 | HSP90AB1 (0.57) | HSP90AB1HSP90AA1CYP2C19JAK2 | |
| SCHEMBL3327824 | 0.88 | HSP90AB1 (0.61) | HSP90AB1HSP90AA1CYP2C19JAK2 | |
| SCHEMBL3324933 | 0.88 | HSP90AB1 (0.57) | HSP90AB1HSP90AA1CYP2C19JAK2 | |
| SCHEMBL3320527 | 0.88 | HSP90AB1 (0.75) | HSP90AB1HSP90AA1CYP2C19JAK2 | |
| SCHEMBL31108382 | 0.88 | HSP90AB1 (0.75) | HSP90AB1HSP90AA1CYP2C19JAK2 | |
| SCHEMBL3327826 | 0.86 | HSP90AB1 (0.66) | HSP90AB1HSP90AA1CYP2C19JAK2 | |
| SCHEMBL13917676 | 0.83 | HSP90AB1 (0.67) | HSP90AB1HSP90AA1CYP2C19JAK2 | |
| SCHEMBL4189048 | 0.82 | HSP90AB1 (0.49) | HSP90AB1HSP90AA1CYP2C19 | |
| SCHEMBL13126139 | 0.80 | HSP90AB1 (0.81) | HSP90AB1HSP90AA1CYP2C19JAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090069336-A1 | PYRIMIDOTHIOPHENE COMPOUNDS | Dymock, Brian William (GB) | 2009-03-12 | — | — | US | disclosed |
| US-20090069336-A1 | PYRIMIDOTHIOPHENE COMPOUNDS | Dymock, Brian William (GB) | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069336-A1 | PYRIMIDOTHIOPHENE COMPOUNDS | ALK, NRAS, ROS1 | HSP90AB1 5/4885HSP90AA1 6/4885CYP2C19 1376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.